Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis ; volume:20 ; number:1 ; day:26 ; month:8 ; year:2020 ; pages:1-7 ; date:12.2020
BMC cardiovascular disorders ; 20, Heft 1 (26.8.2020), 1-7, 12.2020
- Creator
-
Norouzi, Somayye
Javinani, Ali
Aminorroaya, Arya
Masoumi, Maryam
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-020-01676-x
- URN
-
urn:nbn:de:101:1-2020101419460403305984
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Norouzi, Somayye
- Javinani, Ali
- Aminorroaya, Arya
- Masoumi, Maryam
- SpringerLink (Online service)
Other Objects (12)
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Erratum: Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Anti-citrullinated protein antibody and rheumatoid factor in patients with end-stage renal disease
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Erratum: Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Anti-citrullinated protein antibody and rheumatoid factor in patients with end-stage renal disease
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Erratum: Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Anti-citrullinated protein antibody and rheumatoid factor in patients with end-stage renal disease